In Alzheimer's disease, the imperative to foster phagocytosis while mitigating inflammation emerges; however, the anti-inflammatory signaling of TREM2 may inadvertently disrupt the body's intrinsic anti-tumor defenses or exacerbate pro-fibrotic responses in the aftermath of liver injury (15). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.